drugset / Trial / NCT04467450

Ultrasound Guided Botulinum Toxin Type A Injection of Subacromial-Subdeltoid Bursa in Hemiplegic Shoulder Pain

NCT04467450

Phase 0 Unknown 36 enrolled Benha University
RandomizedParallel-groupSingle-blindTreatment

Summary

Good shoulder function is a prerequisite for effective hand function, as well as for performing multiple tasks involving mobility, ambulation, and activities of daily living (ADL). A common sequela of stroke is hemiplegic shoulder pain, which can hamper functional recovery and subsequently lead to disability. Hemiplegic shoulder pain can begin as early as 2 weeks post stroke but typically occurs within 2-3 months post stroke.

Timeline

Start
2020-06-01
Primary completion
2020-11-20
Completion
2020-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 20 iu Other
Comparator Methyl Prednisolonate Small molecule 40 mg Other

Indications